🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate safety, tolerability, pharmacokinetics and pharmacodynamics ...
Status
Completed
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT02259959
The primary objective of this study is to assess the safety of 52 weeks onc...
Status
Completed
Location
1237.22.81015 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01536262
Treatments Being Tested
The deleterious consequences of lung hyperinflation seem not to be restrict...
Status
Completed
Location
Kingston General Hospital
Start Date
2017-01-01
Trial ID
NCT03425617
Treatments Being Tested
This is a 4-week, multicenter, randomized, double-blind, parallel group and...
Status
Completed
Location
Ordination Dr. Robert Voves, 8330 Feldbach
Start Date
2016-03-08
Trial ID
NCT02683109
Treatments Being Tested
This protocol describes a randomised controlled trial to test the hypothesi...
Status
Completed
Location
NHS Tayside
Start Date
2017-06-01
Trial ID
NCT03152149
Treatments Being Tested
Study to collect the data on Chronic Obstructive Pulmonary Disease (COPD) p...
Status
Completed
Location
Ditmanson Medical Foundation Chia - Yi Christian Hospital
Start Date
2019-12-29
Trial ID
NCT04011475
Treatments Being Tested
This study looks at data from people with chronic obstructive pulmonary dis...
Status
Completed
Location
eMax health
Start Date
2021-12-17
Trial ID
NCT05169424
The primary objective of this study is to determine the optimum dose(s) of ...
Status
Completed
Location
1237.9.00152 Boehringer Ingelheim Investigational Site
Start Date
2008-07
Trial ID
NCT00720499
Treatments Being Tested
The objective of this study is to assess the efficacy and safety of 12 week...
Status
Completed
Location
1237.26.10620 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT02006732
Treatments Being Tested
The primary objective of this study is to assess the effect of umeclidinium...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-07-14
Trial ID
NCT02799784
Treatments Being Tested